Sharemaestro Newsreel

Hims & Hers Health, Inc. (HIMS) Reports Q2 Loss, Tops Revenue Estimates

Hims & Hers Health, Inc. (HIMS) came out with a quarterly loss of $0.1 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to earnings of $0.17 per share a year ago. These figures are adjusted for non-recurring items. …

What Is Behind Veeva Systems (VEEV) Latest Move?

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Broker Signals On Veeva Systems Stock A fresh wave of brokerage opinions on Veeva Systems (VEEV) has put the stock back in focus for investors, …

Wall Street Bulls Look Optimistic About Veeva (VEEV): Should You Buy?

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price. Do they really matter, though? Let's …

Notable healthcare headlines for the week: Eli Lilly, Novo Nordisk, and Pfizer in focus

Wall Street’s major market averages ended higher on Friday after July's nonfarm payrolls surprised to the downside, showing an unexpected contraction in employment. The blue-chip Dow edged up 0.3%, the benchmark S&P 500 gained 0.62%, and the tech-focused Nasdaq Composite jumped 1.3%. The S&P …

Veeva Systems Inc (VEEV) Gewinnprognose: Zukünftige EPS & Umsatzwachstumsprognosen

VEEV Prognose — Kursziel für 2027

Veeva Systems Stock Beats Q4 Guidance With $836M Revenue and $3.2B Full Year

Veeva Systems Guides $3.6 Billion for 2027, Well Above Estimates: Here’s The $327 Bull Case

Veeva Systems steigert Gewinn und Umsatz im ersten Quartal und gibt Prognose bekannt

Veeva Systems Aktie (A1W5SA, VEEV) - Kurs, Chart, News & Kennzahlen